The Kaiser Family Foundation (KFF) recently released an issue brief analyzing the 2017 prescription drug (Part D) plan offerings based on recently released data from the Center for Medicare and Medicaid Services (CMS). The key findings in KFF’s analysis come at an important time as millions of people with Medicare are weighing their plan choices during Fall Open Enrollment, which lasts from October 15 to December 7.

The Affordable Care Act (ACA) requires Marketplace plans to keep people unless they ask to disenroll or stop paying their premiums under a consumer protection called “guaranteed renewability.” This means that people have a right to keep a plan that they are in and their plan cannot drop them because they become older or sicker.

In a recently proposed rule, the Centers for Medicare & Medicaid Services (CMS) asks whether this protection conflicts with a longstanding Medicare law that prohibits a health plan from selling a policy to a person who already has Medicare. Medicare Rights responded that guaranteed renewability should be maintained, based on both the simple reading of the law and on fundamental fairness.

This week, the Medicare Rights Center released a new brief on the complexities of knowing when to enroll in Medicare Part D and the consequences of making mistakes. The brief, Medicare Snapshot: Stories from the Helpline, Part D Enrollment: Penalty Pitfalls, reports on a recurring issue heard on the Medicare Rights national helpline.

Last week, the Medicare Rights Center and partner organizations, including Justice in Aging, the Center for Medicare Advocacy, and the National Council on Aging, wrote to the Acting Administrator of the Centers for Medicare and Medicaid Services (CMS), to urge the agency to revisit the policy that allows certain private insurance companies to automatically enroll certain people into Medicare Advantage plans.

The Centers for Medicare and Medicaid Services (CMS) recently announced Part D plan participants for a new demonstration, the Enhanced Medication Therapy Management Model, that seeks to strengthen Medication Therapy Management (MTM) services in Part D. In 2003, the Medicare Modernization Act was enacted, creating the Part D program and requiring every Part D plan to offer an MTM program. MTM programs are meant to improve quality of care by ensuring people are taking their medications safely and as prescribed, addressing any barriers to their doing so, and bringing any medication issues to the attention of the treating physician. CMS claims that these activities can also create cost savings.

A new bill, the Fair Drug Pricing Act, was introduced in both the Senate and the House this month promising to bring greater transparency to increases in drug prices.

The Medicare Rights Center (Medicare Rights) responded to a request for information (RFI) from the Centers for Medicare & Medicaid Services (CMS) asking about inappropriate steering practices encouraging people into coverage that is not right for them. CMS raises concerns about whether providers, plans, or others who stand to gain from an individual’s enrollment decisions may improperly influence people who may be eligible for Medicare or Medicaid to decline public health insurance and retain private market coverage or convince people to give up private market coverage in favor of Medicare or Medicaid.

Congress took steps this week to improve Medicare coverage and enrollment rules by introducing the “The Medicare Affordability and Enrollment Act of 2016.” If passed, the bill would create an out-of-pocket spending cap, reform the Medicare enrollment process by reducing penalties and gaps in coverage, and increase support for lower-income beneficiaries.

A new Kaiser Family Foundation (KFF) issue brief analyzes when people with Medicare make changes to their Medicare Advantage and Part D coverage. The paper highlights beneficiaries enrolled in Medicare Advantage plans with prescription drug coverage (MA-PDs) who change plans when given the opportunity.